Lifeboat Foundation

Named “speech by crowd,” the Debater A.I. groups and summarizes large numbers of disparate arguments made by individuals.

This week at MIT, academics and industry officials compared notes, studies, and predictions about AI and the future of work. During the discussions, an insurance company executive shared details about one AI program that rolled out at his firm earlier this year. A chatbot the company introduced, the executive said, now handles 150,000 calls per month.

Later in the day, a panelist—David Fanning, founder of PBS’s Frontline—remarked that this statistic is emblematic of broader fears he saw when reporting a new Frontline documentary about AI. “People are scared,” Fanning said of the public’s AI anxiety.

Fanning was part of a daylong symposium about AI’s economic consequences—good, bad, and otherwise— convened by MIT’s Task Force on the Work of the Future.

The news: Alphabet X, the company’s early research and development division, has unveiled the Everyday Robot project, whose aim is to develop a “general-purpose learning robot.” The idea is to equip robots with cameras and complex machine-learning software, letting them observe the world around them and learn from it without needing to be taught every potential situation they may encounter.

For now: The early prototype robots are learning how to sort trash. It sounds mundane, but it’s tough to get robots to identify different types of objects, and then how to grasp them. Alphabet X claims that its robots are currently putting less than 5% of trash in the wrong place, versus an error rate of 20% among the office’s humans.

The big idea: Robots are expensive and confined to performing very specific, specialized tasks. Getting robots that can operate safely and autonomously in messy, complex human environments like homes or offices is one of the biggest challenges in robotics right now.

This article originally appeared in the Aug. 19, 2019 issue of SpaceNews magazine.

When the Aerospace Corp. launched the Optical Communications and Sensor Demonstration in 2017, one mission objective was to test water-fueled thrusters. At the time, the idea was fairly novel. Two years later, water-based propulsion is moving rapidly into the mainstream.

Capella Space’s first radar satellite and HawkEye 360’s first cluster of three radio-frequency mapping satellites move in orbit by firing Bradford Space’s water-based Comet electrothermal propulsion system. Momentus Space and Astro Digital are testing a water plasma thruster on their joint El Camino Real mission launched in July. And an updated version of the water-fueled cold gas thrusters the Aerospace Corp. first flew in 2017 launched in early August.

But a company spokesperson called the cancelled program “important and necessary.”

It was predicted four decades ago, but only found now.

Just seven years after scientists announced the first use of Crispr-Cas9 gene editing technology on human cells, researchers shared new evidence this week that Crispr can be used to cure two serious genetic disorders.

On Tuesday, NPR reported that a patient in Nashville had seen a dramatic decline in her symptoms of sickle cell disease after receiving a single gene therapy treatment in July. Sickle cell, which can lead to inflammation, debilitating pain, and life-threatening circulatory problems, affects millions of people around the world.

That same day, the biotech companies behind the sickle-cell treatment, Crispr Therapeutics and Vertex, also shared promising results from their first attempt to cure a case of beta thalassemia, another genetic disorder that affects blood proteins. Nine months after receiving the experimental treatment, a patient in Germany with beta thalassemia has almost no signs of the disorder.

Increases in life span are one of the greatest success stories of modern society. Yet, while most of us can expect to live longer, we are spending more years in ill health. Reducing this period of ill health at the end of life is the main aim of a group of scientists known as biogerontologists.

By studying aging in animals, including fruit flies, worms, and rodents, biogerontologists have identified biological phenomena involved with aging that all these organisms share. And some of these biological processes may also regulate aging in humans.

Scientists attempting to understand and improve the aging process have identified many molecules that appear to improve aging in these animals (although evidence in humans remains scant). These molecules include compounds found in grapes, apples, and even bacteria.